Low Dose Tolvpatan (7.5 Mg) Is Effective in the Management of SIADH in Oncology Patients (Results From a Retrospective Audit at the Christie Hospital and Wythenshawe Pulmonary Oncology Unit)
Endocrine Abstracts
doi 10.1530/endoabs.34.p89
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2014
Authors
Publisher
Bioscientifica